Three PE/VC firms lead financing for AI-driven drug company

SoftBank Vision Fund 2, PICC Capital and Morningside co-led a $318 million financing of XtalPi, an artificial intelligence-based drug discovery and development company based in Massachusetts and China.

Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since built a team with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D and algorithm design. XtalPi's cutting-edge technologies have led to the establishment of strategic partnerships with top international pharmaceutical companies.

The SoftBank Vision Fund was formed to accelerate the AI revolution through investments in market . . .

Continue Reading

Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.

Get started

Back to top button

Start Your Days in the Know

 

Get fresh alts intel in your inbox with our FREE newsletter!

You have Successfully Subscribed!